Early apixaban therapy after ischemic stroke in patients with atrial fibrillation
ConclusionsSymptomatic HT rates are likely to be low in randomized trials of DOAC initiation post-stroke. Recurrent ischemic stroke may be the major clinical outcome. These data may be used as expected event rates when calculating sample size requirements for future safety/efficacy trials of early versus late DOAC initiation after AF-related stroke.
Source: Journal of Neurology - Category: Neurology Source Type: research
More News: Atrial Fibrillation | Brain | CT Scan | Disability | Hemorrhagic Stroke | Infectious Diseases | Ischemic Stroke | MRSA | Neurology | PET Scan | Stroke | Study | Superbugs